(Q48301035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

main subject

angiogenesis inhibitor

1 reference

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Khalid Bajou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Victor L Thijssen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Agnes Noel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

18

Arjan W Griffioen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

21

Peter Carmeliet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

16

Stefan Vinckier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Stephanie Herkenne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Salvino D'Amico

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ngoc-Quynh-Nhu Nguyen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ann Bouché

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sébastien Tabruyn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mohammed Srahna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jean-Yves Carabin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Olivier Nivelles

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Cécile Paques

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ivo Cornelissen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Michelle Lion

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ann Gils

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Mieke Dewerchin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Joseph A Martial

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ingrid Struman

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

15 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

741-747

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24929950%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.3552

20 March 2020

exact match

0 references

cites work

Targeting the tumour vasculature: insights from physiological angiogenesis

1 reference

Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

21 January 2018

1 reference

Vasoinhibins: endogenous regulators of angiogenesis and vascular function.

21 January 2018

1 reference

Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth

21 January 2018

1 reference

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

21 January 2018

1 reference

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation.

21 January 2018

1 reference

The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation

21 January 2018

1 reference

Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia

21 January 2018

1 reference

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

21 January 2018

1 reference

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

21 January 2018

1 reference

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

21 January 2018

1 reference

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

21 January 2018

1 reference

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

21 January 2018

1 reference

alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor

21 January 2018

1 reference

The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation

21 January 2018

1 reference

TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots

21 January 2018

1 reference

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

21 January 2018

1 reference

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

21 January 2018

1 reference

Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein.

21 January 2018

1 reference

Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis

21 January 2018

1 reference

Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis

21 January 2018

1 reference

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk

21 January 2018

1 reference

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

21 January 2018

1 reference

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

Thrombotic events in patients with cancer receiving antiangiogenesis agents

21 January 2018

1 reference

Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation

21 January 2018

1 reference

Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

21 January 2018

1 reference

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

21 January 2018

1 reference

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells

21 January 2018

1 reference

Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization

21 January 2018

1 reference

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis

21 January 2018

1 reference

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model

21 January 2018

1 reference

12 December 2020

A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor

1 reference

12 December 2020

Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin)

1 reference

12 December 2020

Identification of functional synergism between monoclonal antibodies. Application to the enhancement of plasminogen activator inhibitor-1 neutralizing effects

1 reference

12 December 2020

Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma

1 reference

12 December 2020

uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view

1 reference

12 December 2020

Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

1 reference

12 December 2020

16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway

1 reference

12 December 2020

A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells

1 reference

12 December 2020

Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy

1 reference

12 December 2020

16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells

1 reference

12 December 2020

Lack of plasminogen activator inhibitor-1 enhances the preventive effect of DX-9065a, a selective factor Xa inhibitor, on venous thrombus and acute pulmonary embolism in mice

1 reference

12 December 2020

Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo

1 reference

12 December 2020

Antitumor activity of the 16-kDa prolactin fragment in prostate cancer

1 reference

12 December 2020

Immunological characterization of plasminogen activator activities in human tissues and body fluids

1 reference

12 December 2020

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

1 reference

12 December 2020

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

1 reference

12 December 2020

Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin

1 reference

12 December 2020

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

1 reference

12 December 2020